Icogenex Bioincubator

Biotech backed by Gates Foundation raises $14M more Just Biotherapeutics develops technology to make it easier and cheaper to manufacture drugs that treat infectious diseases.

PolyDrop, a current tenant at Icogenex Bioincubator, received a $750K NSF SBIR Phase II Award for development and scale-up of DiStart and DiCorr products.

This Small Business Innovation Research Phase II project aims to continue the development of a family ofnew nanostructured conductive additives for use in high-performance coatings and composite resins.

Icogenex Bioincubator rents lab and office space, including use of equipment, amenities, and services at no additional charge, to startup and small biotech companies in the Seattle area.